About this episode
Palantir lifted its 2025 revenue guidance and Pfizer has filed a second lawsuit against Novo Nordisk and obesity drug start-up Metsera. Plus, OpenAI inked a $38bn computing deal with Amazon, and the FT’s Claire Jones explains how the Trump administration is considering pushing for wider global dollar adoption.
Mentioned in this podcast:
Palantir lifts 2025 sales outlook after posting strong quarterly growth
Pfizer files second lawsuit to block Novo Nordisk’s $9bn Metsera bid
OpenAI strikes $38bn computing deal with Amazon
US pushes for wider global dollar adoption
Today’s FT News Briefing was produced by Sonja Hutson, and Marc Filippino. Our show was mixed by Kelly Garry. Additional help from Michela Tindera, Michael Lello and David da Silva. The FT’s acting co-head of audio is Topher Forhecz. The show’s theme music is by Metaphor Music.
Read a transcript of this episode on FT.com
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time FT News Briefing publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from FT News Briefing
Is the global maritime order breaking down?
FT News Briefing
A foldable iPhone: John Ternus’s first test as Apple CEO
FT News Briefing
Extended chat: Top US trade official defends Trump’s record
FT News Briefing
Top US trade official reveals ‘problem’ in UK negotiations
FT News Briefing